Barclays’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.93M Sell
56,473
-58,351
-51% -$7.16M ﹤0.01% 1382
2025
Q1
$11.6M Sell
114,824
-221
-0.2% -$22.4K ﹤0.01% 935
2024
Q4
$10.6M Buy
115,045
+54,167
+89% +$5M ﹤0.01% 1093
2024
Q3
$5.88M Sell
60,878
-8,959
-13% -$866K ﹤0.01% 1420
2024
Q2
$5.99M Sell
69,837
-127,925
-65% -$11M ﹤0.01% 1099
2024
Q1
$16.3M Buy
197,762
+98,717
+100% +$8.15M 0.01% 809
2023
Q4
$6.61M Buy
99,045
+42,101
+74% +$2.81M ﹤0.01% 1309
2023
Q3
$3.82M Sell
56,944
-58,696
-51% -$3.94M ﹤0.01% 1302
2023
Q2
$7.83M Buy
115,640
+40,645
+54% +$2.75M 0.01% 998
2023
Q1
$4.06M Buy
74,995
+53,774
+253% +$2.91M ﹤0.01% 1207
2022
Q4
$1.27M Sell
21,221
-8,022
-27% -$480K ﹤0.01% 1959
2022
Q3
$1.32M Sell
29,243
-14,876
-34% -$672K ﹤0.01% 1926
2022
Q2
$1.97M Buy
44,119
+30,771
+231% +$1.37M ﹤0.01% 1596
2022
Q1
$756K Sell
13,348
-59,924
-82% -$3.39M ﹤0.01% 2515
2021
Q4
$3.8M Sell
73,272
-208,154
-74% -$10.8M ﹤0.01% 1408
2021
Q3
$16.8M Sell
281,426
-25,235
-8% -$1.51M 0.01% 741
2021
Q2
$19M Buy
306,661
+273,225
+817% +$17M 0.01% 702
2021
Q1
$2.18M Buy
33,436
+14,981
+81% +$975K ﹤0.01% 1788
2020
Q4
$1.21M Sell
18,455
-10,722
-37% -$705K ﹤0.01% 1868
2020
Q3
$1.51M Sell
29,177
-14,662
-33% -$757K ﹤0.01% 1675
2020
Q2
$2.16M Buy
43,839
+12,532
+40% +$617K ﹤0.01% 1419
2020
Q1
$1.6M Sell
31,307
-1,680
-5% -$85.6K ﹤0.01% 1457
2019
Q4
$1.82M Sell
32,987
-2,237
-6% -$123K ﹤0.01% 1948
2019
Q3
$1.77M Sell
35,224
-69,562
-66% -$3.5M ﹤0.01% 1855
2019
Q2
$5.28M Sell
104,786
-12,223
-10% -$616K ﹤0.01% 1074
2019
Q1
$5.44M Sell
117,009
-14,128
-11% -$656K ﹤0.01% 950
2018
Q4
$6.44M Buy
131,137
+9,804
+8% +$481K 0.01% 867
2018
Q3
$7.53M Sell
121,333
-37,214
-23% -$2.31M 0.01% 871
2018
Q2
$8.54M Buy
158,547
+91,050
+135% +$4.91M 0.01% 789
2018
Q1
$3.07M Buy
67,497
+27,627
+69% +$1.26M ﹤0.01% 1135
2017
Q4
$1.57M Buy
39,870
+17,010
+74% +$669K ﹤0.01% 1394
2017
Q3
$843K Sell
22,860
-718
-3% -$26.5K ﹤0.01% 1682
2017
Q2
$907K Buy
23,578
+13,762
+140% +$529K ﹤0.01% 1615
2017
Q1
$335K Sell
9,816
-22,256
-69% -$760K ﹤0.01% 2194
2016
Q4
$1.05M Buy
32,072
+28,559
+813% +$936K ﹤0.01% 1463
2016
Q3
$114K Buy
3,513
+2,178
+163% +$70.7K ﹤0.01% 2392
2016
Q2
$41K Sell
1,335
-1,330
-50% -$40.8K ﹤0.01% 2632
2016
Q1
$78K Buy
2,665
+2,152
+419% +$63K ﹤0.01% 2398
2015
Q4
$14K Sell
513
-851
-62% -$23.2K ﹤0.01% 2761
2015
Q3
$41K Sell
1,364
-54,481
-98% -$1.64M ﹤0.01% 2651
2015
Q2
$2.04M Buy
55,845
+39,989
+252% +$1.46M ﹤0.01% 1156
2015
Q1
$557K Sell
15,856
-9,209
-37% -$324K ﹤0.01% 1883
2014
Q4
$758K Sell
25,065
-40,250
-62% -$1.22M ﹤0.01% 1767
2014
Q3
$1.87M Buy
65,315
+6,490
+11% +$186K ﹤0.01% 1408
2014
Q2
$1.64M Buy
58,825
+15,294
+35% +$426K ﹤0.01% 1460
2014
Q1
$1.21M Sell
43,531
-11,751
-21% -$327K ﹤0.01% 1573
2013
Q4
$1.45M Buy
55,282
+27,590
+100% +$724K ﹤0.01% 1556
2013
Q3
$749K Buy
27,692
+4,179
+18% +$113K ﹤0.01% 1871
2013
Q2
$539K Buy
+23,513
New +$539K ﹤0.01% 2156